Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol.
Yeung DT, Eadie LN, Rehn J, Heatley SL, McClure BJ, Page EC, Schutz CE, Osborn MP, Trahair T, Sutton R, Henderson MJ, Kwan J, Mapp S, Dalla-Pozza L, Bradstock K, Greenwood M, White DL. Yeung DT, et al. Among authors: sutton r. Blood Neoplasia. 2024 Sep 16;2(1):100041. doi: 10.1016/j.bneo.2024.100041. eCollection 2025 Feb. Blood Neoplasia. 2024. PMID: 40546727 Free PMC article.
An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL.
Greenwood M, Trahair T, Sutton R, Osborn M, Kwan J, Mapp S, Howman R, Anazodo A, Wylie B, D'Rozario J, Hertzberg M, Irving I, Yeung D, Coyle L, Jager A, Engeler D, Venn N, Frampton C, Wei AH, Bradstock K, Dalla-Pozza L. Greenwood M, et al. Among authors: sutton r. Blood Adv. 2021 Dec 28;5(24):5574-5583. doi: 10.1182/bloodadvances.2021005576. Blood Adv. 2021. PMID: 34662896 Free PMC article.
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab.
Sutton R, Pozza LD, Khaw SL, Fraser C, Revesz T, Chamberlain J, Mitchell R, Trahair TN, Bateman CM, Venn NC, Law T, Ong E, Heatley SL, McClure BJ, Meyer C, Marschalek R, Henderson MJ, Cross S, White DL, Kotecha RS. Sutton R, et al. Pediatr Blood Cancer. 2021 May;68(5):e28922. doi: 10.1002/pbc.28922. Epub 2021 Feb 26. Pediatr Blood Cancer. 2021. PMID: 33638292
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
Venn NC, Huang L, Hovorková L, Muskovic W, Wong M, Law T, Heatley SL, Khaw SL, Revesz T, Dalla Pozza L, Shaw PJ, Fraser C, Moore AS, Cross S, Bendak K, Norris MD, Henderson MJ, White DL, Cowley MJ, Trahair TN, Zuna J, Sutton R. Venn NC, et al. Among authors: sutton r. Br J Cancer. 2022 Sep;127(5):908-915. doi: 10.1038/s41416-022-01806-6. Epub 2022 Jun 1. Br J Cancer. 2022. PMID: 35650277 Free PMC article.
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.
Thomson AJ, Rehn JA, Heatley SL, Eadie LN, Page EC, Schutz C, McClure BJ, Sutton R, Dalla-Pozza L, Moore AS, Greenwood M, Kotecha RS, Fong CY, Yong ASM, Yeung DT, Breen J, White DL. Thomson AJ, et al. Among authors: sutton r. Cancers (Basel). 2023 Sep 26;15(19):4731. doi: 10.3390/cancers15194731. Cancers (Basel). 2023. PMID: 37835427 Free PMC article.
2,020 results